Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Florian Hecker
,
Mani Arsalan
,
Thomas Walther
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) has become the default treatment option for high-risk patients with aortic stenosis (AS) and, based on heart team discussion, an alternative to surgical aortic valve replacement (SAVR) in intermediate-risk patients.
TAVR has led to a paradigm shift in the basic therapeutic principle to treat AS: calcifications, in some patients quite excessive, are…
View more
Author(s):
Roberto Spina
,
Chris Anthony
,
David WM Muller
,
et al
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) with either the balloonexpandable Edwards SAPIEN XT valve (Edwards Lifesciences, Irvine, California), or the self-expandable CoreValve prosthesis (Medtronic, Minneapolis, Minnesota) has become the established therapeutic modality for severe aortic valve stenosis in patients who are not deemed suitable for surgical intervention due to excessively high…
View more
TAVR in Bicuspid Disease
Author(s):
Nicolas M Van Mieghem
,
Basel Ramlawi
,
Didier Tchétché
,
et al
Start date:
Jun 04, 2020
Broadcast
Author(s):
Hemal Gada
,
Kendra J Grubb
Added:
1 year ago
Dr Hemal Gada (UPMC Heart and Vascular Institute, US) and his team published an informative review article on “Transcatheter Aortic Valve Replacement Optimization Strategies: Cusp Overlap, Commissural Alignment, Sizing, and Positioning”, in a comprehensive special focus issue on the “Lifetime Management of Patients With Aortic Stenosis” edited byDr Kendra Grubb(Emory Structural Heart and Valve…
View more
Impact on Implantation Depth
Author(s):
Verena Veulemans
,
Oliver Maier
,
Tobias Zeus
Added:
1 month ago
Article
Author(s):
Lars G Svensson
Added:
3 years ago
If you can look into the seeds of time and say which grain will grow and which will not speak then to me. Macbeth; William Shakespeare.
Predictions of the role of transcatheter aortic valve replacement (TAVR) in moderate-risk patients is fraught with potential pitfalls. The matrix of outcomes is interlinked and changes in one cell may have consequences beyond currently observable measures. For…
View more
Author(s):
Samir R Kapadia
Added:
1 year ago
TCT 22 - In this short interview, Dr Samir Kapadia (Cleveland Clinic, OH, US) outlines the findings of the PROTECTED-TAVR trial, which aimed to demonstrate the performance of Boston Scientific's Sentinel® Cerebral Protection System in transcatheter aortic valve replacement.
In this study, 3000 patients were randomized to receive either TAVR with the Sentinel system or TAVR without intervention…
View more
Transcatheter Aortic Valve Replacement and Left Atrial Appendage Occlusion - A Stitch in Time?
Author(s):
Sameer Gafoor
,
Luisa Heuer
,
Jennifer Franke
,
et al
Added:
3 years ago
Article
Author(s):
Angela McInerney
,
Rafael Vera-Urquiza
,
Gabriela Tirado-Conte
,
et al
Added:
2 years ago